Transversus Abdominis Plan Block Versus Rectus Sheath Block
Launched by SISLI HAMIDIYE ETFAL TRAINING AND RESEARCH HOSPITAL · Mar 20, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two different methods of pain relief used during and after a surgery called abdominoplasty, which is a procedure to remove excess skin and fat from the abdomen. The two methods being studied are the Transversus Abdominis Plane Block and the Rectus Sheath Block. Both techniques aim to help reduce pain after surgery and lessen the need for stronger pain medications, like opioids.
To be eligible for this study, participants should be adults aged 18 to 65 who are scheduled for elective abdominoplasty surgery and have a body weight between 50 and 80 kg. The trial is not open to individuals with serious health issues, those under 18, or anyone who has certain medical conditions that would make these pain relief methods unsafe. If you decide to participate, you can expect to receive one of the pain relief methods during your surgery, and researchers will monitor your pain levels and recovery closely. This study may help improve pain management techniques for future patients undergoing similar procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who will undergo elective abdominoplasty
- • Patients between the ages of 18-65
- • ASA (American Society of Anesthesiologists) I-II-III patients
- • Patients with a body weight between 50-80 kg
- Exclusion Criteria:
- • - ASA IV patient group
- • Patients under 18 years of age
- • Patients without cooperation
- • Patients with chronic alcohol use
- • Patients in whom peripheral plane block application is contraindicated (infection at the application site, coagulopathy, local anesthetic allergy)
- • Patients who do not want to participate in the study
About Sisli Hamidiye Etfal Training And Research Hospital
Sisli Hamidiye Etfal Training and Research Hospital is a prominent healthcare institution dedicated to advancing medical research and education. Located in Istanbul, Turkey, the hospital is affiliated with the Ministry of Health and serves as a leading center for clinical trials, providing comprehensive services in various medical specialties. With a strong commitment to improving patient outcomes and contributing to scientific knowledge, Sisli Hamidiye Etfal fosters collaboration among healthcare professionals, researchers, and academic institutions. The hospital is equipped with state-of-the-art facilities and adheres to the highest ethical standards, ensuring the integrity and safety of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
LEYLA KILINC
Study Chair
şişli etfal eğitim araştırma hastanesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported